(Q40197352)

18 September 2017

1 reference

title

The aggressive peripheral T-cell lymphomas: 2017. (English)

1 reference

18 September 2017

1

James O Armitage

1 reference

18 September 2017

publication date

18 May 2017

1 reference

American Journal of Hematology

18 September 2017

published in

1 reference

18 September 2017

volume

92

1 reference

18 September 2017

issue

7

1 reference

18 September 2017

page(s)

706-715

1 reference

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

18 September 2017

cites work

1 reference

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes

21 January 2018

1 reference

Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas

21 January 2018

1 reference

Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations

21 January 2018

1 reference

Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma

21 January 2018

1 reference

Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas

21 January 2018

1 reference

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells

21 January 2018

1 reference

Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies

21 January 2018

1 reference

F-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas

21 January 2018

1 reference

Assessment of metabolic activity by PET-CT with F-18-FDG in patients with T-cell lymphoma.

21 January 2018

1 reference

18F-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS group.

21 January 2018

1 reference

Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma.

21 January 2018

1 reference

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

21 January 2018

1 reference

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.

21 January 2018

1 reference

Anaplastic large-cell lymphoma in women with breast implants

21 January 2018

1 reference

Breast implant-associated ALCL: a unique entity in the spectrum of CD30+ lymphoproliferative disorders

21 January 2018

1 reference

Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma

21 January 2018

1 reference

Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials

21 January 2018

1 reference

Peripheral T-cell lymphoma, not otherwise specified

21 January 2018

1 reference

EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.

21 January 2018

1 reference

Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients

21 January 2018

1 reference

Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type

21 January 2018

1 reference

Risk of malignancy in patients with celiac disease.

21 January 2018

1 reference

Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.

21 January 2018

1 reference

Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology

21 January 2018

1 reference

Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: case report and literature review

21 January 2018

1 reference

Case records of the Massachusetts General Hospital. Case 8-2008. A 33-year-old man with fever, abdominal pain, and pancytopenia after renal transplantation

21 January 2018

1 reference

Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.

21 January 2018

1 reference

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group

21 January 2018

1 reference

Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology

21 January 2018

1 reference

Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial.

21 January 2018

1 reference

Crizotinib as salvage and maintenance with allogeneic stem cell transplantation for refractory anaplastic large cell lymphoma.

21 January 2018

1 reference

Crizotinib in anaplastic large-cell lymphoma

21 January 2018

1 reference

Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantation.

21 January 2018

1 reference

Stem-cell transplantation in T-cell non-Hodgkin's lymphomas

21 January 2018

1 reference

Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma

21 January 2018

1 reference

Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.

21 January 2018

1 reference

High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factors

21 January 2018

1 reference

The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.

21 January 2018

1 reference

Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group

21 January 2018

1 reference

Advances in the understanding and management of angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry

21 January 2018

1 reference

Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial.

21 January 2018

1 reference

Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience

21 January 2018

1 reference

Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study

21 January 2018

1 reference

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

21 January 2018

1 reference

Interim report of a phase 2 clinical trial of lenalidomide for T-cell non-Hodgkin lymphoma

21 January 2018

1 reference

Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma

21 January 2018

1 reference

L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation

21 January 2018

1 reference

How I treat NK/T-cell lymphomas

21 January 2018

1 reference

Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan.

21 January 2018

1 reference

Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation

21 January 2018

1 reference

Brentuximab in the treatment of CD30-positive enteropathy-associated T-cell lymphoma.

21 January 2018

1 reference

Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients

21 January 2018

1 reference

Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine

21 January 2018

1 reference

2'-Deoxycoformycin for hepatosplenic gammadelta T-cell lymphoma

21 January 2018

1 reference

Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment

21 January 2018

1 reference

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

Intestinal lymphoma associated with malabsorption

21 January 2018

1 reference

Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.

21 January 2018

1 reference

Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/AJH.24791

1 reference

18 September 2017

1 reference